The place of VMAT-2 inhibitors for the treatment of tardive dyskinesia: A meta-analysis of randomized controlled trials

被引：0
|
作者：
Solmi, M. [1 ]
Pigato, G. [2 ]
Correll, C. [3 ]
机构：
[1] Univ Padua, Neurosci Dept, Padua, Italy
[2] Univ Hosp Padua, Psychiat, Padua, Italy
[3] Univ Padua, Neurosci, Padua, Italy
来源：
EUROPEAN PSYCHIATRY | 2018年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
OR0166
引用
收藏
页码：S131 / S132
页数：2
相关论文
共 50 条
  • [1] Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
    Solmi, Marco
    Pigato, Giorgio
    Kane, John M.
    Correll, Christoph U.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1215 - 1238
  • [2] A new class of VMAT-2 inhibitors for tardive dyskinesia
    Correll, Christoph U.
    Carbon, Maren
    LANCET PSYCHIATRY, 2017, 4 (08): : 572 - 573
  • [3] FEASIBILITY OF A COMPARATIVE META-ANALYSIS OF VMAT2 INHIBITORS FOR THE TREATMENT OF TARDIVE DYSKINESIA
    Caroff, S. M.
    Aggarwal, S.
    Yonan, C.
    VALUE IN HEALTH, 2017, 20 (05) : A189 - A189
  • [4] Extract of Ginkgo biloba for Tardive Dyskinesia: Meta-analysis of Randomized Controlled Trials
    Zheng, W.
    Xiang, Y. -Q.
    Ng, C. H.
    Ungvari, G. S.
    Chiu, H. F. K.
    Xiang, Y. -T.
    PHARMACOPSYCHIATRY, 2016, 49 (03) : 107 - 111
  • [5] Dissemination of VMAT-2 Inhibitors: A New Class Drug for Tardive Dyskinesia and Huntington Disease
    Ma, Erica
    Krening, Emma
    Bruno, Michiko K.
    NEUROLOGY-CLINICAL PRACTICE, 2025, 15 (01)
  • [6] VMAT2 Inhibitors for the Treatment of Tardive Dyskinesia
    Warren, Barbara
    Vanderhoef, Dawn
    Johnson, Jessica
    ISSUES IN MENTAL HEALTH NURSING, 2022, 43 (01) : 22 - 31
  • [7] VMAT2 inhibitors for the treatment of tardive dyskinesia
    Scorr, Laura M.
    Factor, Stewart A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 389 : 43 - 47
  • [8] VMAT2 Inhibitors: New Drugs for the Treatment of Tardive Dyskinesia
    Kim, Anne P.
    Baker, Danial E.
    Levien, Terri L.
    CONSULTANT PHARMACIST, 2018, 33 (04): : 201 - 209
  • [9] Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials
    Tammenmaa, IA
    Sailas, E
    McGrath, JJ
    Soares-Weiser, K
    Wahlbeck, K
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2004, 28 (07): : 1099 - 1107
  • [10] Treatment for Dyskinesia in Parkinson's Disease: A Network Meta-analysis of Randomized Controlled Trials
    Yan, Rui
    Zheng, Xiaoqing
    Yin, Yixuan
    Zhang, Junjiao
    Cui, Yusha
    Su, Dongning
    Wan, Zhirong
    Feng, Tao
    MOVEMENT DISORDERS, 2025,
12345